| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | DAZAP2 CAMTA2 CLOCK CREB1 CREBBP CREM CRY2 LATS1 ARID2 LRP2 NCOA1 TAF4B SPEN HCFC1 HTT | 8.14e-05 | 753 | 126 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.32e-04 | 303 | 126 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | chromatin binding | EP400 IFT74 RBL2 CAMTA2 MLLT10 ATAD2 CLOCK CREBBP CIC PHF21A RING1 TOX3 NCOA1 HCFC1 | 2.39e-04 | 739 | 126 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.00e-04 | 51 | 126 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 4.02e-04 | 55 | 126 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 5.61e-04 | 60 | 126 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 8.13e-04 | 7 | 126 | 2 | GO:0019770 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | CCND1 CAMTA2 SRCAP CREBBP TSC22D1 TOX3 PKM NCOA1 SPEN HCFC1 MRTFA | 8.74e-04 | 562 | 126 | 11 | GO:0003712 |
| GeneOntologyCellularComponent | transcription regulator complex | NRF1 RBL2 LIN54 DAZAP2 CCND1 CLOCK CREB1 CREBBP CREM RXRG E2F8 CRY2 ARID2 NCOA1 TAF4B SPEN | 6.13e-07 | 596 | 126 | 16 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | EP400 INO80C LIN54 RBM42 SRCAP CLOCK CREB1 PABPC1 CREBBP CREM RXRG E2F8 PHF21A RING1 CRY2 ARID2 DOCK7 NCOA1 TAF4B SRRM2 HCFC1 | 7.32e-05 | 1377 | 126 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | ATF4-CREB1 transcription factor complex | 2.15e-04 | 4 | 126 | 2 | GO:1990589 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 2.48e-04 | 272 | 126 | 8 | GO:0090575 | |
| GeneOntologyCellularComponent | INO80-type complex | 6.27e-04 | 28 | 126 | 3 | GO:0097346 | |
| Domain | pKID | 1.24e-04 | 3 | 121 | 2 | PF02173 | |
| Domain | KID | 1.24e-04 | 3 | 121 | 2 | PS50953 | |
| Domain | Coactivator_CBP_pKID | 1.24e-04 | 3 | 121 | 2 | IPR003102 | |
| Domain | HSA | 2.48e-04 | 4 | 121 | 2 | SM00573 | |
| Domain | Leuzip_CREB | 2.48e-04 | 4 | 121 | 2 | IPR001630 | |
| Domain | HSA | 2.48e-04 | 4 | 121 | 2 | PS51204 | |
| Domain | HSA_dom | 2.48e-04 | 4 | 121 | 2 | IPR014012 | |
| Domain | HSA | 2.48e-04 | 4 | 121 | 2 | PF07529 | |
| Domain | Nuc_rcpt_coact | 6.14e-04 | 6 | 121 | 2 | IPR009110 | |
| Domain | DUF3398 | 6.14e-04 | 6 | 121 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 6.14e-04 | 6 | 121 | 2 | IPR021816 | |
| Domain | Ig-like_fold | PRTG TRIM2 DAG1 CAMTA2 IGSF11 MET HMCN2 FCGR2B SCN2B NECTIN4 HCFC1 PLXNA1 TREML2 | 6.64e-04 | 706 | 121 | 13 | IPR013783 |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 4.43e-06 | 70 | 87 | 6 | M938 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 2.18e-05 | 55 | 87 | 5 | M27145 | |
| Pathway | WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT | 3.91e-05 | 62 | 87 | 5 | M45532 | |
| Pathway | PID_HIF1_TFPATHWAY | 5.30e-05 | 66 | 87 | 5 | M255 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 9.79e-05 | 15 | 87 | 3 | M48323 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 1.45e-04 | 17 | 87 | 3 | M48240 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.52e-04 | 44 | 87 | 4 | M27295 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 1.73e-04 | 18 | 87 | 3 | M27901 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 2.05e-04 | 19 | 87 | 3 | M39544 | |
| Pathway | WP_MITOCHONDRIAL_GENE_EXPRESSION | 2.05e-04 | 19 | 87 | 3 | MM15973 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.32e-04 | 49 | 87 | 4 | M41832 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.71e-04 | 272 | 87 | 8 | M29619 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 3.14e-04 | 96 | 87 | 5 | M26973 | |
| Pathway | KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M48983 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 5.33e-04 | 26 | 87 | 3 | M2499 | |
| Pathway | PID_RXR_VDR_PATHWAY | 5.33e-04 | 26 | 87 | 3 | M162 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 5.40e-04 | 61 | 87 | 4 | M39540 | |
| Pathway | BIOCARTA_CIRCADIAN_PATHWAY | 5.56e-04 | 6 | 87 | 2 | M22067 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 5.97e-04 | 27 | 87 | 3 | M26943 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 6.11e-04 | 63 | 87 | 4 | M27862 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | RBL2 PSMB4 CCND1 GPRIN1 ATAD2 CREB1 CREBBP RXRG E2F8 CCNB1 RING1 MET ZNF776 ARID2 ZNF587 TAF4B ZNF543 ZNF417 HTT | 6.71e-04 | 1387 | 87 | 19 | M734 |
| Pathway | BIOCARTA_CIRCADIAN_PATHWAY | 7.75e-04 | 7 | 87 | 2 | MM1578 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 8.07e-04 | 118 | 87 | 5 | M27316 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 8.17e-04 | 30 | 87 | 3 | M207 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | NUMBL PUF60 DOCK9 DAG1 TBC1D22B GPRIN1 NHSL1 BAIAP2L1 SSH3 PKM NECTIN4 PKP2 LRRC7 TANC1 HCFC1 EPB41L1 | 3.75e-10 | 565 | 129 | 16 | 25468996 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NUMBL IFT74 TBC1D22B WNK1 PABPC1 CIC E2F8 NHSL1 LATS1 BAIAP2L1 DOCK7 PKP2 TANC1 TRAPPC14 SRRM2 EPB41L1 OTOG | 2.24e-08 | 861 | 129 | 17 | 36931259 |
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 22198373 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 22386572 | ||
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 16207717 | ||
| Pubmed | EP400 PUF60 IFT74 SRCAP GPRIN1 CREBBP LATS1 ARID2 DOCK7 PKM SPEN HCFC1 HTT | 1.46e-07 | 549 | 129 | 13 | 38280479 | |
| Pubmed | Ca2+-dependent block of CREB-CBP transcription by repressor DREAM. | 1.99e-07 | 4 | 129 | 3 | 12198160 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 12391146 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | NUMBL DOCK9 DAG1 TBC1D22B ATAD2 PLIN2 MET BAIAP2L1 DOCK7 PKP2 TANC1 PLXNA1 EPB41L1 | 2.19e-07 | 569 | 129 | 13 | 30639242 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 IFT74 LIN54 SRCAP WNK1 CREB1 CREBBP CIC ZC3H7A BAIAP2L1 ARID2 TANC1 SPEN | 3.18e-07 | 588 | 129 | 13 | 38580884 |
| Pubmed | ACSL6 EP400 DOCK9 CAMTA2 ZFR2 DOCK7 DZIP3 LRRC7 SRRM2 SPEN EPB41L1 | 3.81e-07 | 407 | 129 | 11 | 12693553 | |
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 29466738 | ||
| Pubmed | 5.07e-07 | 255 | 129 | 9 | 15324660 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | KLHL24 EP400 MLLT10 WNK1 PABPC1 CIC LATS1 BAIAP2L1 ARID2 SPEN MRTFA | 6.54e-07 | 430 | 129 | 11 | 35044719 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | EP400 NRF1 PUF60 IFT74 RBL2 LIN54 PSMB4 CREB1 CREBBP CREM CIC PHF21A PKM SPEN HCFC1 | 7.33e-07 | 857 | 129 | 15 | 25609649 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EP400 NRF1 PUF60 DOCK9 MLLT10 SRCAP WNK1 CIC NBPF1 NHSL1 ORAI1 TANC1 HERC1 SPEN HCFC1 PLXNA1 HTT | 7.58e-07 | 1105 | 129 | 17 | 35748872 |
| Pubmed | Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock. | 9.89e-07 | 6 | 129 | 3 | 20930143 | |
| Pubmed | 1.14e-06 | 281 | 129 | 9 | 24163370 | ||
| Pubmed | EP400 INO80C LIN54 PSMB4 MLLT10 SRCAP CREB1 PABPC1 CREBBP CIC PHF21A RING1 ARID2 LRP2 NCOA1 HERC1 SRRM2 SPEN HCFC1 | 1.42e-06 | 1429 | 129 | 19 | 35140242 | |
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 1.73e-06 | 7 | 129 | 3 | 16860316 | |
| Pubmed | 2.61e-06 | 104 | 129 | 6 | 9205841 | ||
| Pubmed | 2.75e-06 | 8 | 129 | 3 | 8616895 | ||
| Pubmed | EP400 PUF60 LIN54 CREB1 PABPC1 CREBBP CIC E2F8 PHF21A CCNB1 ARID2 PKM NCOA1 SRRM2 SPEN HCFC1 | 3.50e-06 | 1103 | 129 | 16 | 34189442 | |
| Pubmed | DCDC1 EP400 INO80C FAT3 ADNP2 SRCAP CREBBP PHF21A HMCN2 ARID2 RTL9 LRP2 PKP2 TANC1 TAF4B SRRM2 | 4.05e-06 | 1116 | 129 | 16 | 31753913 | |
| Pubmed | 4.12e-06 | 9 | 129 | 3 | 21072211 | ||
| Pubmed | Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. | 5.26e-06 | 31 | 129 | 4 | 19898483 | |
| Pubmed | 6.33e-06 | 347 | 129 | 9 | 17114649 | ||
| Pubmed | 7.64e-06 | 268 | 129 | 8 | 33640491 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EP400 NUMBL PUF60 SRCAP GPRIN1 WNK1 PABPC1 RTN1 CIC PHF21A SPAG5 ARID2 PKM HCFC1 | 1.03e-05 | 934 | 129 | 14 | 33916271 |
| Pubmed | MLLT10 SRCAP ATAD2 CLOCK CREM CIC PHF21A TSC22D1 ARID2 TOX3 NCOA1 PLXNA1 MRTFA | 1.03e-05 | 808 | 129 | 13 | 20412781 | |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 1.07e-05 | 12 | 129 | 3 | 14645221 | |
| Pubmed | Heart neurons use clock genes to control myocyte proliferation. | 1.08e-05 | 37 | 129 | 4 | 34851661 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21766169 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 2531080 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 23966689 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 31729060 | ||
| Pubmed | Genotype-phenotype correlations in Rubinstein-Taybi syndrome. | 1.37e-05 | 2 | 129 | 2 | 18792986 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21079758 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15265911 | ||
| Pubmed | Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. | 1.37e-05 | 2 | 129 | 2 | 16456924 | |
| Pubmed | Cyclic AMP response element-binding protein is required for normal maternal nurturing behavior. | 1.37e-05 | 2 | 129 | 2 | 15893884 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 26844702 | ||
| Pubmed | Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. | 1.37e-05 | 2 | 129 | 2 | 15585582 | |
| Pubmed | Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. | 1.37e-05 | 2 | 129 | 2 | 15994095 | |
| Pubmed | Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. | 1.37e-05 | 2 | 129 | 2 | 16766198 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 9006899 | ||
| Pubmed | The catalytic subunit of the SWR1 remodeler is a histone chaperone for the H2A.Z-H2B dimer. | 1.37e-05 | 2 | 129 | 2 | 24507717 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 33067265 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 34142702 | ||
| Pubmed | Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies. | 1.37e-05 | 2 | 129 | 2 | 24291262 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 18491248 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 21998402 | ||
| Pubmed | Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. | 1.37e-05 | 2 | 129 | 2 | 22265015 | |
| Pubmed | Phosphorylated CREB binds specifically to the nuclear protein CBP. | 1.37e-05 | 2 | 129 | 2 | 8413673 | |
| Pubmed | Early alteration of epigenetic-related transcription in Huntington's disease mouse models. | 1.37e-05 | 2 | 129 | 2 | 29967375 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 24065533 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 7809053 | ||
| Pubmed | Mechanism of pKID/KIX Association Studied by Molecular Dynamics Free Energy Simulations. | 1.37e-05 | 2 | 129 | 2 | 27054660 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 7916662 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 1461747 | ||
| Pubmed | CCND1 and MET genomic amplification during malignant transformation of a giant cell tumor of bone. | 1.37e-05 | 2 | 129 | 2 | 21098327 | |
| Pubmed | The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis. | 1.37e-05 | 2 | 129 | 2 | 11988318 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15897899 | ||
| Pubmed | PGC-1α regulates the cell cycle through ATP and ROS in CH1 cells. | 1.37e-05 | 2 | 129 | 2 | 26834014 | |
| Pubmed | SARS-CoV-2 infection activates CREB/CBP in cellular cyclic AMP-dependent pathways. | 1.37e-05 | 2 | 129 | 2 | 36477795 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22895714 | ||
| Pubmed | Association study of CREB1 and CBP genes with Alzheimer's disease in Han Chinese. | 1.37e-05 | 2 | 129 | 2 | 28856841 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 16267218 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 11264541 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 32712449 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12165570 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 17568789 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 12650930 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 9516136 | ||
| Pubmed | Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform. | 1.37e-05 | 2 | 129 | 2 | 8605879 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 8552098 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 22116937 | ||
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 35339471 | ||
| Pubmed | Cell-specific occupancy of an extended repertoire of CREM and CREB binding loci in male germ cells. | 1.37e-05 | 2 | 129 | 2 | 20920259 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 29044198 | ||
| Pubmed | Expression profiling of cyclin B1 and D1 in cervical carcinoma. | 1.37e-05 | 2 | 129 | 2 | 16614707 | |
| Pubmed | 1.37e-05 | 2 | 129 | 2 | 15691874 | ||
| Pubmed | ADNP2 WNK1 CREB1 CREBBP CIC ZC3H7A TSC22D1 LATS1 KIAA1549L ARID2 | 1.45e-05 | 486 | 129 | 10 | 20936779 | |
| Pubmed | NUMBL PUF60 RBM42 DAZAP2 WNK1 CIC SPAG5 KIAA1549L DZIP3 LRP2 SPEN | 1.76e-05 | 608 | 129 | 11 | 16713569 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.88e-05 | 398 | 129 | 9 | 35016035 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | RBL2 DAZAP2 MLLT10 CLOCK CREB1 CREBBP CIC RXRG E2F8 TOX3 SPEN HCFC1 MRTFA | 2.44e-05 | 877 | 129 | 13 | 20211142 |
| Pubmed | 2.76e-05 | 418 | 129 | 9 | 34709266 | ||
| Pubmed | EP400 IFT74 SRCAP ATAD2 WNK1 CREBBP SPAG5 RING1 DOCK7 DZIP3 SPEN | 3.02e-05 | 645 | 129 | 11 | 25281560 | |
| Pubmed | NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain. | 3.26e-05 | 17 | 129 | 3 | 34637754 | |
| Pubmed | 3.26e-05 | 17 | 129 | 3 | 19183483 | ||
| Pubmed | 3.26e-05 | 17 | 129 | 3 | 28291835 | ||
| Pubmed | 3.81e-05 | 245 | 129 | 7 | 19521500 | ||
| Pubmed | 3.91e-05 | 18 | 129 | 3 | 9858769 | ||
| Pubmed | 4.06e-05 | 102 | 129 | 5 | 11214970 | ||
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 18070920 | ||
| Pubmed | Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. | 4.09e-05 | 3 | 129 | 2 | 11607033 | |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 12196545 | ||
| Pubmed | Roles of CLOCK phosphorylation in suppression of E-box-dependent transcription. | 4.09e-05 | 3 | 129 | 2 | 19414601 | |
| Pubmed | 4.09e-05 | 3 | 129 | 2 | 18957421 | ||
| Pubmed | The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC. | 4.09e-05 | 3 | 129 | 2 | 35242498 | |
| Interaction | CDH1 interactions | NUMBL PUF60 DOCK9 DAG1 TBC1D22B GPRIN1 CREBBP CCNB1 NHSL1 MET BAIAP2L1 SSH3 PKM NECTIN4 PKP2 LRRC7 TANC1 HCFC1 EPB41L1 | 3.02e-07 | 768 | 126 | 19 | int:CDH1 |
| Interaction | FEV interactions | EP400 LIN54 PSMB4 MLLT10 CREB1 CREBBP CIC PHF21A RING1 ARID2 | 6.02e-07 | 203 | 126 | 10 | int:FEV |
| Interaction | SOX9 interactions | 2.54e-06 | 97 | 126 | 7 | int:SOX9 | |
| Interaction | YWHAH interactions | NUMBL IFT74 DOCK9 TBC1D22B WNK1 CREBBP CIC E2F8 NHSL1 LATS1 BAIAP2L1 DOCK7 PKP2 NCOA1 TANC1 HERC1 TRAPPC14 SRRM2 EPB41L1 HTT OTOG | 4.57e-06 | 1102 | 126 | 21 | int:YWHAH |
| Interaction | FHL2 interactions | EP400 NRF1 PUF60 WNK1 CREB1 CREBBP PHF21A TOX3 ZNF417 SPEN MRTFA HTT | 7.29e-06 | 396 | 126 | 12 | int:FHL2 |
| Interaction | CTBP1 interactions | EP400 RBL2 RPS6KB1 CCND1 CREBBP CIC CRY2 DZIP3 PKP2 SRRM2 SPEN HTT | 9.36e-06 | 406 | 126 | 12 | int:CTBP1 |
| Interaction | ETS1 interactions | 1.11e-05 | 121 | 126 | 7 | int:ETS1 | |
| Interaction | WWTR1 interactions | EP400 PUF60 IFT74 SRCAP GPRIN1 CLOCK CREBBP LATS1 ARID2 DOCK7 HCFC1 HTT | 1.38e-05 | 422 | 126 | 12 | int:WWTR1 |
| Interaction | HNF1B interactions | 2.62e-05 | 190 | 126 | 8 | int:HNF1B | |
| Interaction | C11orf52 interactions | NUMBL DOCK9 GPRIN1 MET BAIAP2L1 DOCK7 PKP2 TANC1 PLXNA1 EPB41L1 | 2.63e-05 | 311 | 126 | 10 | int:C11orf52 |
| Interaction | SRF interactions | 2.72e-05 | 139 | 126 | 7 | int:SRF | |
| Interaction | GSK3A interactions | PUF60 CREB1 PABPC1 RTN1 CREM SPAG5 NHSL1 BAIAP2L1 FCGR2B DOCK7 TANC1 SRRM2 | 3.50e-05 | 464 | 126 | 12 | int:GSK3A |
| Interaction | RUNX1 interactions | 3.73e-05 | 324 | 126 | 10 | int:RUNX1 | |
| Interaction | DAZ1 interactions | 3.80e-05 | 11 | 126 | 3 | int:DAZ1 | |
| Interaction | TAF1 interactions | 3.82e-05 | 260 | 126 | 9 | int:TAF1 | |
| Interaction | FGFR1 interactions | NUMBL PCDHB7 TBC1D22B GPRIN1 CREBBP RTN1 CCNB1 NHSL1 MET BAIAP2L1 PKM PKP2 TANC1 ARMH4 | 4.19e-05 | 632 | 126 | 14 | int:FGFR1 |
| Interaction | LYN interactions | NUMBL RPS6KB1 GPRIN1 CREBBP MET BAIAP2L1 FCGR2B TOX3 DOCK7 PKP2 TANC1 SRRM2 PLXNA1 EPB41L1 HTT | 4.43e-05 | 720 | 126 | 15 | int:LYN |
| Interaction | TAF4 interactions | 5.69e-05 | 156 | 126 | 7 | int:TAF4 | |
| Interaction | HNF4A interactions | 5.89e-05 | 275 | 126 | 9 | int:HNF4A | |
| Interaction | FHL3 interactions | 6.06e-05 | 276 | 126 | 9 | int:FHL3 | |
| Interaction | RAB35 interactions | NUMBL DOCK9 DAG1 GPRIN1 LATS1 BAIAP2L1 DOCK7 LRP2 PKP2 TANC1 PLXNA1 EPB41L1 HTT | 6.28e-05 | 573 | 126 | 13 | int:RAB35 |
| Interaction | SIAH1 interactions | 8.13e-05 | 223 | 126 | 8 | int:SIAH1 | |
| Interaction | EEF1A1 interactions | PUF60 PSMB4 CCND1 PABPC1 CREBBP CIC CRY2 MICALL2 PKM GAPDHS SRRM2 CCDC191 HCFC1 PLXNA1 HTT | 8.39e-05 | 762 | 126 | 15 | int:EEF1A1 |
| Interaction | ELF4 interactions | 8.55e-05 | 115 | 126 | 6 | int:ELF4 | |
| Interaction | KLF15 interactions | 8.85e-05 | 290 | 126 | 9 | int:KLF15 | |
| Interaction | NFIX interactions | 9.20e-05 | 227 | 126 | 8 | int:NFIX | |
| Interaction | YY1 interactions | EP400 INO80C LIN54 SRCAP CREB1 CREBBP CIC RING1 ARID2 DZIP3 HCFC1 | 1.33e-04 | 454 | 126 | 11 | int:YY1 |
| Interaction | E2F3 interactions | 1.37e-04 | 79 | 126 | 5 | int:E2F3 | |
| Interaction | RUNX2 interactions | 1.42e-04 | 126 | 126 | 6 | int:RUNX2 | |
| Interaction | YEATS4 interactions | 1.49e-04 | 182 | 126 | 7 | int:YEATS4 | |
| Interaction | SOX7 interactions | 1.64e-04 | 82 | 126 | 5 | int:SOX7 | |
| Interaction | LHX3 interactions | 1.65e-04 | 185 | 126 | 7 | int:LHX3 | |
| Interaction | RB1 interactions | 1.87e-04 | 394 | 126 | 10 | int:RB1 | |
| Interaction | CREB1 interactions | 1.99e-04 | 254 | 126 | 8 | int:CREB1 | |
| Interaction | RORB interactions | 2.11e-04 | 47 | 126 | 4 | int:RORB | |
| Interaction | KLF8 interactions | 2.28e-04 | 329 | 126 | 9 | int:KLF8 | |
| Interaction | KDM1A interactions | EP400 IFT74 INPP4A LIN54 CLOCK CIC PHF21A SPAG5 C4orf17 DOCK7 DZIP3 LRP2 TMEM266 KRT38 MRTFA HTT | 2.59e-04 | 941 | 126 | 16 | int:KDM1A |
| Interaction | YWHAG interactions | NUMBL PUF60 DOCK9 TBC1D22B WNK1 PABPC1 CIC E2F8 NHSL1 LATS1 BAIAP2L1 DOCK7 PKP2 TANC1 TRAPPC14 SRRM2 EPB41L1 HTT OTOG | 2.73e-04 | 1248 | 126 | 19 | int:YWHAG |
| Cytoband | 19q13.43 | 1.11e-04 | 87 | 129 | 4 | 19q13.43 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.84e-05 | 17 | 82 | 3 | 486 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.92e-04 | 25 | 82 | 3 | 775 | |
| GeneFamily | Cadherin related | 2.64e-03 | 17 | 82 | 2 | 24 | |
| GeneFamily | RNA binding motif containing | 2.83e-03 | 213 | 82 | 5 | 725 | |
| GeneFamily | CD molecules|Membrane spanning 4-domains | 2.97e-03 | 18 | 82 | 2 | 958 | |
| GeneFamily | CD molecules|Mucins | 4.03e-03 | 21 | 82 | 2 | 648 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-07 | 169 | 129 | 7 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.55e-06 | 157 | 129 | 6 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.55e-06 | 157 | 129 | 6 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.55e-06 | 157 | 129 | 6 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-06 | 169 | 129 | 6 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 173 | 129 | 6 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-05 | 184 | 129 | 6 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-05 | 186 | 129 | 6 | 24b23880d4ff8fb4a23e2012d5890b9e2fcf7283 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-05 | 187 | 129 | 6 | 0689058ccc68cbccc227700a80e920326e2a4a8c | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 188 | 129 | 6 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-05 | 191 | 129 | 6 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.00e-05 | 191 | 129 | 6 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-05 | 193 | 129 | 6 | 525e0de0f25f3308daf49e7d4c8774562f1f40ad | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-05 | 193 | 129 | 6 | 2d18f39615043dfbff120a00f6540ffa93082c83 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 194 | 129 | 6 | 550e61a40be2baa59520aaf5912bb99ad094ba15 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-05 | 194 | 129 | 6 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-05 | 194 | 129 | 6 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-05 | 195 | 129 | 6 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 197 | 129 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.38e-05 | 197 | 129 | 6 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-05 | 198 | 129 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-05 | 198 | 129 | 6 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | tumor_Lung-Epithelial_cells-tS2|tumor_Lung / Location, Cell class and cell subclass | 2.51e-05 | 199 | 129 | 6 | 28ec59e01061287fb0892491790b316e2b93e232 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-05 | 200 | 129 | 6 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-05 | 200 | 129 | 6 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.59e-05 | 200 | 129 | 6 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.14e-05 | 148 | 129 | 5 | 9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 8.61e-05 | 154 | 129 | 5 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 8.88e-05 | 155 | 129 | 5 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.00e-04 | 159 | 129 | 5 | e47d9fefa9e9fcc7812336874a456077ec44b722 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.00e-04 | 159 | 129 | 5 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 161 | 129 | 5 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.06e-04 | 161 | 129 | 5 | 283012858e575c70d09950de53da041509f59bfa | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 162 | 129 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 165 | 129 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 166 | 129 | 5 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-04 | 166 | 129 | 5 | de319c960b0cd90b294f677d1ea1b013a2ce2d53 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 166 | 129 | 5 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 166 | 129 | 5 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-04 | 167 | 129 | 5 | d1a13d6ada572d8ddb2da95e6e122d2b705fad7f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.37e-04 | 170 | 129 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 170 | 129 | 5 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 171 | 129 | 5 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-04 | 171 | 129 | 5 | 38a05b5ec8ef8f09a2399994c6b4b9a707918ec1 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 172 | 129 | 5 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-04 | 176 | 129 | 5 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 176 | 129 | 5 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-04 | 177 | 129 | 5 | 3535575686c9700ab72700aae6f2070ebbb50044 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-04 | 178 | 129 | 5 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.70e-04 | 178 | 129 | 5 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-04 | 178 | 129 | 5 | fce60ce6b662f1bdaa3b4da43800c6c22fe89533 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-04 | 178 | 129 | 5 | b19c906e067b07eadfd68934d9330b447e24c708 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 179 | 129 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 180 | 129 | 5 | fc5b9d0e3215652e490ca72d69f776e9725608b2 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 180 | 129 | 5 | 6763b22f2383931c747b37cd0ae2f60b08f64d90 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 181 | 129 | 5 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 181 | 129 | 5 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 181 | 129 | 5 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-04 | 182 | 129 | 5 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | HSPCs-LMPPs|World / Lineage and Cell class | 1.93e-04 | 183 | 129 | 5 | e401f06843528a75693ce455bbeff2a98b8c24e5 | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 184 | 129 | 5 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 184 | 129 | 5 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 184 | 129 | 5 | da8d6e7944eb35e6cbea2feb7cbc2894787d723f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 184 | 129 | 5 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.03e-04 | 185 | 129 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 185 | 129 | 5 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.03e-04 | 185 | 129 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.08e-04 | 186 | 129 | 5 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-04 | 187 | 129 | 5 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 188 | 129 | 5 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | 3'_v3-GI_small-bowel|World / Manually curated celltypes from each tissue | 2.19e-04 | 188 | 129 | 5 | 822c6abaf7bcd6721269bdbd1f2b286ccf0aec1a | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 188 | 129 | 5 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.19e-04 | 188 | 129 | 5 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 189 | 129 | 5 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.29e-04 | 103 | 129 | 4 | d8965b338b90ddc0686ea0d94e9a330128566c39 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 2.30e-04 | 190 | 129 | 5 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.30e-04 | 190 | 129 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.30e-04 | 190 | 129 | 5 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | (7)_Epithelial-G_(Club-Clara_cells)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.30e-04 | 190 | 129 | 5 | 593fd1451038b155826a48de4caa38f44406d0b9 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-04 | 191 | 129 | 5 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 2.35e-04 | 191 | 129 | 5 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.35e-04 | 191 | 129 | 5 | 7bad04f8afa949ea952c5c0d71eec43271ade680 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.35e-04 | 191 | 129 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.41e-04 | 192 | 129 | 5 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 2.41e-04 | 192 | 129 | 5 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 192 | 129 | 5 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 2.47e-04 | 193 | 129 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.47e-04 | 193 | 129 | 5 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.47e-04 | 193 | 129 | 5 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | normal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass | 2.59e-04 | 195 | 129 | 5 | b46544ad5af04f4dbc2643637caa3d2d50d922ae | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 195 | 129 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-04 | 195 | 129 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-04 | 195 | 129 | 5 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 196 | 129 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-04 | 196 | 129 | 5 | efeb272bc9e37e60d15d056b7574991c5c7501bc | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 196 | 129 | 5 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.71e-04 | 197 | 129 | 5 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-04 | 197 | 129 | 5 | a1ae1aa797762a3768e14434c7e5cd19c595ecb3 | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A | TRIM2 DOCK9 RBM42 MLLT10 CREM CRY2 MICALL2 TRAPPC14 SRRM2 MRTFA | 1.48e-07 | 195 | 127 | 10 | 1687_DN |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.53e-06 | 195 | 127 | 9 | 7288_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.60e-06 | 196 | 127 | 9 | 3471_DN | |
| Drug | AGN 194204 | 3.61e-06 | 162 | 127 | 8 | ctd:C430898 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A | 1.08e-05 | 188 | 127 | 8 | 4310_DN | |
| Drug | glutamin | RPS6KB1 PSMB4 CREB1 PABPC1 CREBBP CREM CIC MET BAIAP2L1 NCOA1 GAPDHS HTT | 1.08e-05 | 461 | 127 | 12 | CID000000738 |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 1.36e-05 | 194 | 127 | 8 | 5362_UP | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.36e-05 | 194 | 127 | 8 | 5316_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.36e-05 | 194 | 127 | 8 | 4309_DN | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 1.41e-05 | 195 | 127 | 8 | 6561_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 1.41e-05 | 195 | 127 | 8 | 6200_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.46e-05 | 196 | 127 | 8 | 2103_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.46e-05 | 196 | 127 | 8 | 5288_UP | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; HL60; HT_HG-U133A | 1.52e-05 | 197 | 127 | 8 | 1275_UP | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.52e-05 | 197 | 127 | 8 | 2334_UP | |
| Drug | Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.57e-05 | 198 | 127 | 8 | 2749_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.63e-05 | 199 | 127 | 8 | 6132_DN | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A | 1.69e-05 | 200 | 127 | 8 | 7518_UP | |
| Drug | N6-furfuryladenosine | 2.71e-05 | 11 | 127 | 3 | CID000003832 | |
| Drug | ON123300 | 2.94e-05 | 32 | 127 | 4 | ctd:C000594117 | |
| Drug | PD 173074 | 5.90e-05 | 14 | 127 | 3 | ctd:C115711 | |
| Drug | 3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione | 5.90e-05 | 14 | 127 | 3 | ctd:C417520 | |
| Drug | monobutyl phthalate | 6.87e-05 | 314 | 127 | 9 | ctd:C028577 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 8.49e-05 | 186 | 127 | 7 | 6996_UP | |
| Drug | NSC-364372 | NUMBL RBL2 RPS6KB1 CREB1 CREM CCNB1 CRY2 NCOA1 GAPDHS TAF4B HTT | 8.68e-05 | 484 | 127 | 11 | CID000435143 |
| Drug | P-312 | 9.23e-05 | 3 | 127 | 2 | CID000199977 | |
| Drug | XI-006 | 9.23e-05 | 3 | 127 | 2 | ctd:C000607970 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.70e-05 | 190 | 127 | 7 | 1632_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.70e-05 | 190 | 127 | 7 | 3172_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 9.70e-05 | 190 | 127 | 7 | 4307_DN | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.00e-04 | 191 | 127 | 7 | 4981_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.04e-04 | 192 | 127 | 7 | 3858_UP | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.07e-04 | 193 | 127 | 7 | 4973_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 194 | 127 | 7 | 1707_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.10e-04 | 194 | 127 | 7 | 3855_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 127 | 7 | 4312_DN | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.14e-04 | 195 | 127 | 7 | 5315_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 1.14e-04 | 195 | 127 | 7 | 1639_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.14e-04 | 195 | 127 | 7 | 2071_DN | |
| Drug | deferoxamine mesylate salt; Down 200; 100uM; MCF7; HG-U133A | 1.14e-04 | 195 | 127 | 7 | 573_DN | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 3187_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 3256_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 7183_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.18e-04 | 196 | 127 | 7 | 1662_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 2259_DN | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 6279_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 6623_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 3195_DN | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 5301_DN | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 4974_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 1240_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.22e-04 | 197 | 127 | 7 | 2070_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 3175_DN | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; HL60; HG-U133A | 1.25e-04 | 198 | 127 | 7 | 1977_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 3196_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 6041_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 1806_UP | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 2107_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 6482_DN | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 6352_UP | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 2345_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 6228_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.25e-04 | 198 | 127 | 7 | 1009_DN | |
| Drug | Dioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.25e-04 | 198 | 127 | 7 | 5699_DN | |
| Drug | Phenylephrine | KLHL24 TRIM2 TMEM176B RPS6KB1 CCND1 CREB1 CREBBP CREM GYS2 PKM BOLL | 1.26e-04 | 505 | 127 | 11 | ctd:D010656 |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 3264_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 1488_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 7298_UP | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; HL60; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 2731_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 7254_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 127 | 7 | 5988_DN | |
| Drug | LY294002; Up 200; 10uM; HL60; HG-U133A | 1.33e-04 | 200 | 127 | 7 | 361_UP | |
| Drug | Trazodone hydrochloride [25332-39-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.33e-04 | 200 | 127 | 7 | 7410_DN | |
| Drug | S-ethyl N-phenylisothiourea | 1.75e-04 | 93 | 127 | 5 | CID000347590 | |
| Drug | 2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol | 1.84e-04 | 4 | 127 | 2 | ctd:C439584 | |
| Drug | GSK 1363089 | 1.84e-04 | 4 | 127 | 2 | ctd:C544831 | |
| Drug | TCPOBOP | 1.94e-04 | 95 | 127 | 5 | CID000005382 | |
| Drug | N-nitrosomorpholine | 2.03e-04 | 52 | 127 | 4 | CID000006046 | |
| Drug | o,p'-DDT | 2.24e-04 | 451 | 127 | 10 | ctd:C016340 | |
| Disease | Bowen's Disease | 9.79e-05 | 4 | 120 | 2 | C0006079 | |
| Disease | gut microbiome measurement, bone density | 2.94e-04 | 78 | 120 | 4 | EFO_0003923, EFO_0007874 | |
| Disease | autosomal dominant polycystic kidney disease (biomarker_via_orthology) | 3.40e-04 | 7 | 120 | 2 | DOID:898 (biomarker_via_orthology) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.91e-04 | 84 | 120 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | male breast carcinoma | 4.52e-04 | 8 | 120 | 2 | EFO_0006861 | |
| Disease | malaria (implicated_via_orthology) | 5.80e-04 | 9 | 120 | 2 | DOID:12365 (implicated_via_orthology) | |
| Disease | plexin-B2 measurement | 5.80e-04 | 9 | 120 | 2 | EFO_0021867 | |
| Disease | Carcinoma, Transitional Cell | 6.25e-04 | 41 | 120 | 3 | C0007138 | |
| Disease | serum albumin measurement | 7.21e-04 | 592 | 120 | 9 | EFO_0004535 | |
| Disease | Other specified cardiac arrhythmias | 8.81e-04 | 11 | 120 | 2 | C0348626 | |
| Disease | Nodal rhythm disorder | 8.81e-04 | 11 | 120 | 2 | C0264893 | |
| Disease | Ectopic rhythm | 8.81e-04 | 11 | 120 | 2 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 8.81e-04 | 11 | 120 | 2 | C2748542 | |
| Disease | red blood cell density measurement | DCDC1 EP400 RPS6KB1 LIN54 WNK1 FCGR2C MICALL2 FCGR2B ARID2 TAF4B ARMH4 | 9.46e-04 | 880 | 120 | 11 | EFO_0007978 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.05e-03 | 49 | 120 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Brugada Syndrome 1 | 1.24e-03 | 13 | 120 | 2 | C4551804 | |
| Disease | Squamous cell carcinoma of the head and neck | 1.25e-03 | 52 | 120 | 3 | C1168401 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 1.45e-03 | 14 | 120 | 2 | DOID:3969 (is_marker_for) | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 1.45e-03 | 14 | 120 | 2 | cv:C2931907 | |
| Disease | Diffuse Large B-Cell Lymphoma | 1.48e-03 | 55 | 120 | 3 | C0079744 | |
| Disease | Sinus Node Dysfunction (disorder) | 1.66e-03 | 15 | 120 | 2 | C0428908 | |
| Disease | brain measurement, neuroimaging measurement | 1.88e-03 | 550 | 120 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | obesity (implicated_via_orthology) | 1.90e-03 | 215 | 120 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Seasonal Affective Disorder | 1.90e-03 | 16 | 120 | 2 | C0085159 | |
| Disease | Neoplasm Metastasis | 1.97e-03 | 217 | 120 | 5 | C0027627 | |
| Disease | testosterone measurement | DCHS2 DCDC1 TMEM176B ANKS1B DAG1 IQCN SRCAP CREB1 PLIN2 ZC3H7A BAIAP2L1 RTL9 NCOA1 | 2.08e-03 | 1275 | 120 | 13 | EFO_0004908 |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 2.14e-03 | 17 | 120 | 2 | EFO_0021969 | |
| Disease | Intellectual Disability | 2.40e-03 | 447 | 120 | 7 | C3714756 | |
| Disease | hematocrit | DCDC1 NUMBL LIN54 MET FCGR2C MICALL2 FCGR2B ARID2 GYS2 TOX3 LRP2 | 2.82e-03 | 1011 | 120 | 11 | EFO_0004348 |
| Disease | renal system measurement | 2.97e-03 | 20 | 120 | 2 | EFO_0004742 | |
| Disease | Major Depressive Disorder | 3.21e-03 | 243 | 120 | 5 | C1269683 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.27e-03 | 21 | 120 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | leucine measurement | 3.32e-03 | 73 | 120 | 3 | EFO_0009770 | |
| Disease | Mammary Neoplasms, Experimental | 3.75e-03 | 155 | 120 | 4 | C0024668 | |
| Disease | Prostatic Neoplasms | 3.75e-03 | 616 | 120 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.75e-03 | 616 | 120 | 8 | C0376358 | |
| Disease | Mental Depression | 3.88e-03 | 254 | 120 | 5 | C0011570 | |
| Disease | Huntington's disease (is_implicated_in) | 3.92e-03 | 23 | 120 | 2 | DOID:12858 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSSPGVTTLPMNVAG | 2926 | Q96L91 | |
| VNMSNQVPRSVGSTP | 286 | O95264 | |
| SRSVCSSPVMVAQPI | 161 | Q8N9W6 | |
| AGLMQTERPGVSTPT | 101 | Q86TY3 | |
| PAECTVMGIPSVTTN | 516 | P54840 | |
| APSSSPMGIIVAVVT | 216 | P31994 | |
| QMVTIAGVPSPQASR | 876 | Q68CP9 | |
| ATMVAVPAGADPSTV | 1551 | Q68CP9 | |
| PRPVISMQAQAAVAG | 2036 | Q92793 | |
| RPSMSLAVVVGTEPS | 351 | O94983 | |
| ISNPPSMVAAGSVVA | 196 | P24385 | |
| MIPASQRAVTSPGQA | 686 | Q6PL18 | |
| MGLSPSAPAVAVQAS | 1 | P53701 | |
| SRAVPSGVLPAGQMT | 441 | Q6IQ32 | |
| ASGATIRLPASPVEM | 156 | Q8N7S6 | |
| PVVGITPSQMVANAF | 506 | Q9Y6R0 | |
| ARAAAAATVVPPMVG | 101 | Q9BTD8 | |
| RIGSPPSVVMLVGSS | 1051 | Q9H0B3 | |
| GPITRTQNPMVTGTS | 41 | P28070 | |
| PPVTRSVDTVNGRMV | 181 | Q96PE3 | |
| RVANTSTQTMGPRPA | 481 | P11940 | |
| STQTMGPRPAAAAAA | 486 | P11940 | |
| PPSVSVSLGQMARIT | 26 | A0A075B6K0 | |
| PVPGQTLVTMATATV | 721 | Q08999 | |
| MNGETTRPRCPVQTV | 801 | Q7Z6G8 | |
| TGTPLVTMRPASQAG | 496 | P51610 | |
| QRFPQSVVTTPMSRG | 9401 | Q8WXI7 | |
| QSVAVGPLGSTIPMA | 76 | Q15038 | |
| GRRVAACQPATMVPT | 1586 | M0R2J8 | |
| AAAMIPGPQTVATEI | 766 | Q9H4G0 | |
| NTTPVRMSVPIVSAQ | 396 | Q6MZP7 | |
| SSVPVGRQPIIMQSS | 321 | O95835 | |
| GASQTRPVSARPTMA | 1211 | Q96NW7 | |
| AVAVAVAGAPGTVMP | 16 | Q8NDA2 | |
| MAPGARNVSVSPIDI | 16 | O76015 | |
| AEAGRNVMVPAAAPS | 4011 | Q15751 | |
| SEAGTTVPGQIRPTM | 391 | Q14118 | |
| PGQAAAIASTTIMVP | 231 | Q96D31 | |
| AAGSMSPSRVEANVP | 1271 | Q5SYE7 | |
| VPRQPGAMGVDSRTS | 256 | Q8IY33 | |
| APSSSPMGIIVAVVT | 216 | P31995 | |
| TMPGIATFSSRPQAV | 216 | Q9H2K0 | |
| TMVCRAPSVANPVRS | 1101 | Q9UIW2 | |
| GPVQVAMAPVTTRIS | 471 | Q16656 | |
| ATATMPASVVGQRPT | 141 | Q96BD5 | |
| PASVVGQRPTIAMVT | 146 | Q96BD5 | |
| VTMSGEASAPLPIRQ | 486 | P23443 | |
| RPGSGFTNTMRVVPV | 516 | P14618 | |
| VTSAPGTMTRPRAGV | 1591 | Q6ZVL6 | |
| FRVPIVNSSLVMPSG | 2541 | P98164 | |
| TPSVVAIVGPQLSMF | 66 | O43934 | |
| VPGPTSSATNVSMVV | 531 | Q3BBV0 | |
| PQMAPVAITLVSDGT | 196 | Q86X67 | |
| GVVSATGQPRAPLMT | 991 | Q86Y13 | |
| VITVDASRPQPFMGV | 241 | O95800 | |
| VTDRGSPPRNATMAV | 1266 | Q6V1P9 | |
| VSTPGCVSVRDRMVP | 706 | Q2VWP7 | |
| MAAQIPIVATTSTPG | 1 | Q6PI98 | |
| VPENSPVGSMVVSVS | 251 | Q9Y5E2 | |
| MAGAKRVPTAPAATS | 21 | P14635 | |
| PFGAMNIVRTPSVAQ | 96 | Q53FT3 | |
| LSAMTVPVAGNPAVS | 2511 | P42858 | |
| AVPVMVPAQSRAGSL | 416 | Q5DX21 | |
| LSGNIRVATAMPPGT | 31 | Q96LB3 | |
| DPATSIITGVAAMPR | 566 | Q6TFL4 | |
| GTPQASPMIERSNVV | 256 | Q9UHR4 | |
| MVSPTSVAAVPVGNS | 701 | A0AVK6 | |
| MAIAGTSVPQLTRPG | 1291 | Q96N67 | |
| NVRDVSPFPVNAGMT | 1181 | Q9BZ29 | |
| MARSRGPIQSSGPTI | 16 | Q5BKY9 | |
| MAATVATAAAVAPAP | 1 | Q49AN0 | |
| AVNMAGLPAVSIPVA | 451 | Q9H0R6 | |
| GGVPQRVTFPVRSSM | 236 | Q8WW52 | |
| RTCQMLVNSPVASPG | 616 | Q8NCU4 | |
| STAVQESPVRGMSPA | 86 | Q53FE4 | |
| QGSPPMSATAIVRIS | 1646 | Q8TDW7 | |
| RTAPTSTIAPGVVMA | 241 | P16220 | |
| MSAAPASNGVFVVIP | 1 | Q8N5U1 | |
| AETRSVATGPMTPQA | 866 | Q7Z2K8 | |
| TGMAFRVPTPDVSVV | 301 | O14556 | |
| RSSVPMPGVQAVAAT | 101 | Q6ICI0 | |
| MPTVISASVAPRTAA | 1 | P20807 | |
| RAPTAALPQGVVMAA | 256 | Q03060 | |
| PDVGNPMSLARSVSA | 21 | Q92681 | |
| VRRPIPGSDQTTTMS | 156 | Q06587 | |
| VPSRNISVTPEGQTM | 576 | Q12889 | |
| PVAEGTASMVSVVPR | 1901 | Q6ZRI0 | |
| RFMQVVVSRSGPSTP | 461 | P08581 | |
| SNPPVRATASGVMSA | 386 | Q8NET4 | |
| RATASGVMSAPPVRA | 391 | Q8NET4 | |
| LRRAPTSGAMSTQPV | 501 | Q8NET4 | |
| GVSSPLVRAPASGTM | 896 | Q8NET4 | |
| GPARQSPVAMETAST | 66 | Q16799 | |
| GTVTMAPAGALPVRV | 21 | Q92750 | |
| MTLTASPGVFPVTVQ | 186 | Q9NWD8 | |
| GPRRTMGSQTVTASP | 201 | Q5T2D2 | |
| EPVGTRPRVDSMSSV | 391 | Q8NBJ9 | |
| RVASMVSLQPAETPG | 951 | Q96R06 | |
| SGRIETVAQSMPQSP | 781 | Q7Z5M5 | |
| AAGLAARMSQVPAPV | 2201 | Q9UQ35 | |
| RISDQNASGAPPMTV | 166 | Q9NU19 | |
| VMAAQAPGVITGVTP | 371 | Q9UHX1 | |
| VPGPTSSATNVSMVV | 531 | Q5TAG4 | |
| DTNSGMSIPRVNPSV | 376 | Q15788 | |
| PQMGRRTPAQVSSVD | 346 | D6RGX4 | |
| MPGRIAATPAGSRTQ | 1566 | Q9C0D5 | |
| MSAATGIQPSPVNVV | 571 | Q15714 | |
| SASGAAPLPVTMVSR | 1826 | Q6ZRS2 | |
| SPTQVVSQLPMGRDS | 156 | Q969V6 | |
| VIVNGVAMASRPSQP | 6 | Q3YBM2 | |
| MALVTVSRSPPGSGA | 1 | Q8TE77 | |
| GMQPVTSTIPAVSAV | 881 | P55197 | |
| GCVRMIVTGAAPASP | 426 | Q9UKU0 | |
| AAPLSRPAATMVTNV | 661 | Q96RK0 | |
| RPAATMVTNVVRPVS | 666 | Q96RK0 | |
| VISQPAAGSMVQIPS | 666 | O15516 | |
| MAAPAPVTRQVSGAA | 1 | Q7RTV5 | |
| SEIAAGPARISMISP | 171 | Q495C1 | |
| PGRSMEVTVPATLNV | 26 | O60939 | |
| GSRPQEPVPTATTMA | 71 | Q9UPR6 | |
| STNATVMLAAGIPVP | 3051 | Q96T58 | |
| SGSVMERRAITPPVA | 531 | Q8WVR3 | |
| VAGPVAMSQSSPLIA | 171 | Q76KD6 | |
| MAAAVPRRPTQQGTV | 1 | Q96SQ5 | |
| MAAAAPRRPTQQGTV | 1 | Q8TAU3 | |
| RVITSAMGPPSGALA | 71 | P48443 | |
| TDAARSGVMPPAQLT | 161 | O15405 | |
| MPSALVRGPLQTASV | 301 | Q8IWR0 | |
| NPTIVTDVGRPFMTA | 561 | Q08ER8 | |
| MASVAVDPQPSVVTR | 1 | Q99541 | |
| VTSAVGPVSMAAPTA | 1811 | Q9H4A3 | |
| MASEGTNIPSPVVRQ | 1 | Q9C040 | |
| AGSGPMPTSVAQTVV | 711 | Q99959 | |
| SLAPMVASTVANGPR | 181 | Q2M3C6 | |
| MAAAALRPPAQGTVT | 1 | Q68DI1 | |
| VPSRSMNGQPLTCVV | 211 | Q96NY8 |